CD8A and cancer: Clinical studies in centenarians show that these patients do not have increased prevalence of opportunistic infections and/or cancers; on the contrary, longitudinal studies suggest that having lower numbers of CD8+ cells inducing inflammatory responses to cytomegalovirus may be considered a survival advantage in older patients [36,37].